Overview

  • Product name
    Naproxen sodium
  • Description
    Non-selective COX inhibitor
  • Biological description
    Non-selective COX inhibitor (IC50 values are 9.3 and 28 μM at COX-1 and COX-2, respectively). Analgesic, antipyretic and anti-inflammatory effects
  • Purity
    > 99%

Properties

    References for Naproxen sodium (ab141033)

    This product has been referenced in:
    • Levy D  et al. Sensitization of meningeal nociceptors: inhibition by naproxen. Eur J Neurosci 27:917-22 (2008). Read more (PubMed: 18333963) »
    • Dhir A  et al. Protective effect of naproxen (non-selective COX-inhibitor) or rofecoxib (selective COX-2 inhibitor) on immobilization stress-induced behavioral and biochemical alterations in mice. Eur J Pharmacol 535:192-8 (2006). Read more (PubMed: 16522321) »
    • Warner TD  et al. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci U S A 96:7563-8 (1999). Read more (PubMed: 10377455) »
    • Sutton LB Naproxen sodium. J Am Pharm Assoc (Wash) NS36:663-7 (1996). Read more (PubMed: 8952254) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab141033.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"

    Sign up